Targeting EGFR, T790M, ALK, and ROS1 in NSCLC

This program was recorded during a live presentation as part of the 2017 MEDX Oncology conference “Evidence-based Medicine in Oncology Practice: Challenges in Today’s Healthcare Environment” that took place on September 7, 2017 in East Brunswick, NJ.

Jointly provided by Potomac Center for Medical Education, Postgraduate Institute for Medicine and Rockpointe Oncology.